Notice names this product. RAYSEARCH LABORATORIES AB’s RayCare 2024A SP1 is named in FDA Class II recall Z-2646-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change. Identifying details: Software Version 8.0.1.60193, UDI 0735000201083920240906, Expiration Date: 2030-01-24. Units affected: 3 units. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
RayCare 2024A SP1. Oncology Information Systems.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session,…
Company / brand: RAYSEARCH LABORATORIES AB recalls
Affected product: RayCare 2024A SP1 recall status
Official ID Z-2646-2026 · Official record ↗
See all RAYSEARCH LABORATORIES AB recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 6:00 PM UTC.